August 10, 2023 11:43 AM EDT
Pharma
Manufacturing

No­vo Nordisk an­tic­i­pates patchy We­govy sup­ply in the com­ing months as it pro­vides in­sight on man­u­fac­tur­ing plans

Tyler Patchen

News Reporter

De­spite No­vo Nordisk ini­tial­ly sug­gest­ing its US sup­ply short­age for We­govy would ease in Sep­tem­ber, it is now say­ing such con­straints may car­ry on a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times